Johnson & Johnson Highlights Growth Strategies for Pharmaceutical and Consumer Businesses

Expects to File for Five More New Pharmaceutical Compounds by End of 2007;
Anticipates Another 7 to 10 New Compound Filings by End of 2010

With PCH Integration On Track, World’s Premier Consumer Health Care Business
Plans to Build on Iconic Brands Through Superior Science and Innovation

Johnson & Johnson highlighted its Pharmaceutical and Consumer businesses at a meeting with financial analysts today, describing its broadly based health care business as strong and poised for continued growth in the coming years. Senior leaders from the company outlined the current pharmaceutical and consumer business portfolios and growth strategies that will enable the company to capitalize on growing demand in the area of human health and well-being.

Johnson & Johnson’s Vice Chairman Christine Poon underscored how the company believes it is uniquely positioned with its breadth of businesses and flexible operating model to outperform its competitors in a $4 trillion global market for health solutions. “Being broadly based is a cornerstone of our success and will amplify our growth going forward,” Poon said in her opening remarks.

Poon discussed several early-stage ventures that illustrate how the company cultivates innovation across its broad base of businesses. The ventures are based on collaborative work that capitalizes on capabilities and resources across the company’s three businesses – Consumer, Pharmaceuticals, and Medical Devices and Diagnostics.

Poon described projects related to: a treatment for retinitis pigmentosa, which is a hereditary condition leading to blindness; a treatment for uncontrolled bleeding, which is the world’s leading cause of death due to injury; a therapy to fight cancer cells using a patient’s own strengthened immune cells; and a technology for “smart” consumer products that uses tiny molecules to adhere substances onto the body and allow them to be pulled off quickly and easily.

“We have the people, proprietary technology and capabilities of many diverse, entrepreneurial companies,” said Poon. “This enables us to innovate at the intersections of our businesses. That’s an important competitive advantage and why we’re truly more than the sum of our many vibrant businesses.”